Authors
Loading...
Experimental study demonstrates targeted ubiquitination and degradation of MetAP-2 using chimeric Protac-1, suggesting a novel strategy to eliminate disease-causing proteins.
Sakamoto et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: